trending Market Intelligence /marketintelligence/en/news-insights/trending/T_8jUjUVdPiBdFBDA2TlJA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

CVS pulls certain J&J baby powder products amid widening crisis for drugmaker

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


CVS pulls certain J&J baby powder products amid widening crisis for drugmaker

CVS Health Corp. is removing 22-ounce bottles of Johnson & Johnson's baby powder from its shelves, expanding on a small recall the pharmaceutical giant issued six days earlier after a small batch of the product was found to contain cancer-causing asbestos.

Shares of J&J slid by about 1.76% to $127.61 on Oct. 24, continuing a downward trend that began on Oct. 18 when the company announced the recall of a single batch of its talc baby powder products. J&J's shares closed the day Oct. 17 at $136.17.

The U.S. Food and Drug Administration discovered low levels of asbestos in a bottle of the talc product that was purchased online, triggering J&J's voluntarily recall.

CVS, the largest retail pharmacy in the U.S., has now taken a precautionary step of recalling 22-ounce baby powder products from all of its stores, the company confirmed in a statement. The pharmacy also initiated a register warning to prevent the product from being sold as the recall was underway. Customers who purchased the product should not use it and can return the item for a refund, CVS said.

J&J has been dogged by the ongoing talc controversy for months as continued reports on the product's safety crop up. The New Brunswick, N.J.-based company has faced more than 14,000 lawsuits alleging thaht the popular baby powder products cause cancer.

According to the FDA, talc — a naturally occurring mineral — is often mined near its cousin asbestos, which has a different crystal structure. While talc is safe, asbestos is a known carcinogen. The FDA allows no more than 0.00002% of crystalline asbestos contamination in the consumer product.

J&J did not return a request for comment on the matter as of publication.

SNL Image